Gender-affirming hormone therapy may increase risk of high blood pressure

(Beth Israel Deaconess Medical Center) In the largest and longest observational study of its kind, physician-researchers from Beth Israel Deaconess Medical Center (BIDMC) found that gender-affirming hormone therapy (GAHT) was associated with blood pressure changes in both transgender men and women.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news